Dar – the Master Civil Engineer for the Centralny Port Komunikacyjny Airport – Inaugurates Poland Office
25.1.2023 10:30:00 EET | Business Wire | Press release
On January 16, Dar Al-Handasah Consultants – Dar – inaugurated its new Poland office at Aleje Jerozolimskie 142 B 02-305, Warsaw. The move comes after the company began its design activities as the Master Civil Engineer on Poland’s new Centralny Port Komunikacyjny (CPK) Airport.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230124005917/en/
[Right to left] Dar Regional Director of Operations Danny Aoun, Dar Chairman and CEO Talal Shair, HE the Lebanese Ambassador to Poland Reina Charbel, CEO of CPK Mikołaj Wild, and Director of Aviation at CPK Piotr Kasprzyk. (Photo: AETOSWire)
The opening ceremony was attended by Dar’s Chairman and CEO Talal Shair, Regional Director of Operations Danny Aoun, and a team of the company’s leading directors and industry experts. Honored guests at the ceremony included the CEO of CPK Mikołaj Wild, the Director of Aviation at CPK Piotr Kasprzyk, a representative from the Polish national airlines LOT, the Lebanese Ambassador to Poland HE Reina Charbel, as well as senior stakeholders, officials, and subconsultants in Poland’s aviation industry.
Dar’s Chairman and CEO Talal Shair said, “Even as one of the world’s leading aviation design consultants and with our experience in airports around the globe, we were captivated by the sheer vision and ambition of the new airport. And that made it an even greater honour when our company was named the Master Civil Engineer. We are here today to fulfil all of our promises and more, by leveraging our technical excellence and consulting capabilities to help deliver a highly-sustainable, future-fit, and resilient airport that can bolster connections in Europe and position Poland as a continental hub.”
Regional Director of Operations Danny Aoun emphasized Dar’s long-term commitment to Poland, adding, “we are settling in to establish a local team of experts who can tailor our company’s considerable expertise and global credentials to support projects in Poland and Europe deliver even more impact and value to communities across the country.”
About Dar:
Dar is one of the world’s leading consultancies, providing design, planning, engineering, and project management services for a wide variety of market sectors, including buildings and cities, transportation and civil infrastructure, water and the environment. Dar is also the founding member of Dar Group, a global design, engineering, and consulting group with award-winning impact and global reach. In 2022, Dar Group ranked 1st among international design firms in the Airports market as well as 10th among international design firms overall, 3rd in Buildings, and 6th in Transportation (Engineering News Record).
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230124005917/en/
Contact information
Poland office:
Sonia Rutkowska
(+48) 699891333
Sonia.Rutkowska@dar.com
International:
Haya Yahya
009611790002
Haya.yahya@dar.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Netceed Strengthens Board with Global Infrastructure and Technology Leaders1.4.2026 15:00:00 EEST | Press release
Netceed, a global leader in delivering supply chain solutions across broadband, data center and energy infrastructure, today announced the appointment of Franck Bruel, Jan Frykhammar and Stacey Thompson to advise as strategic advisors to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260401045867/en/ Franck Bruel Following the recently announced recapitalization of the Netceed Group and under the chairmanship of Rajeev Suri, the company is strengthening its Board with globally recognized leaders across telecommunications infrastructure, industrial distribution, energy infrastructure and hyperscale technology. Collectively, the new appointees bring decades of leadership experience across some of the world’s most influential infrastructure and technology companies, reflecting Netceed’s ambition to play a leading role in the next generation of global digital, AI and energy infrastructure. Rajeev Suri, Ch
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK ® and TRIKAFTA ® , Expanding Availability of These Medicines to ~95% of All People With CF in the United States1.4.2026 14:30:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK® (vanzacaftor/tezacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 6 and older with a variant in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is either responsive based on clinical and/or in vitro data or results in production of CFTR protein. Additionally, the U.S. FDA has also expanded the indication statement for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in patients ages 2 and older. This label expansion was supported by clinical and/or in vitro data from 564 variants demonstrating response to ALYFTREK and 521 variants demonstrating response to TRIKAFTA. As such, approximately 800 more people with a clinical diagnosis of CF in the U.S. are now eligible for a medicine that treats the underlying cause of their disease for the first time. This extension means approxim
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer1.4.2026 14:30:00 EEST | Press release
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the first patient has been enrolled in the landmark global phase 3 BATTMAN (CO.33) trial (NCT07152821). This study is evaluating Agenus’ immunotherapy combination of botensilimab (BOT) plus balstilimab (BAL) versus best supportive care in patients with refractory, unresectable microsatellite stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC), a population long considered resistant to immunotherapy. This study is being conducted as a cooperative group trial led by the Canadian Cancer Trials Group (CCTG) from Canada and run across Canada, France, Australia and New Zealand. More than 100 sites will participate across the academic cooperative networks of CCTG, GI Cancer Trials in Australia and France’s Partenariat de Recherche en Oncologie Digestive (PRODIGE) consortium (including Unicancer, GERCOR and FFCD). The BATTMAN (CO.33) trial serves as the registrational-enablin
Klarna Agrees to $1.7 Billion Transaction Supporting up to $40B+ of Lending1.4.2026 14:19:00 EEST | Press release
Klarna, the global digital bank and flexible payments provider, has entered into a new capital efficiency transaction in the form of a Significant Risk Transfer (SRT), covering $1.7 billion-worth of Euro denominated loans and freeing up capital to support continued growth. Klarna has entered into a three-year agreement with a consortium led by Värde Partners. This is Klarna's sixth SRT transaction and improves how effectively Klarna deploys its capital on a global basis. "Our banking license is one of our biggest competitive advantages," said Niclas Neglén, Klarna's Chief Financial Officer. "This is our largest and most efficient SRT transaction to date. These transactions allow us to maximize every unit of capital to support our continued momentum." The transaction follows Klarna’s recently announced $2 billion facility supporting $17B of US Financing expansion. About Klarna Klarna is a global digital bank and flexible payments provider. With over 118 million global active Klarna user
Americhem Launches nDryve™: PFAS-Free In-Melt Technology Platform for Functional Fibers1.4.2026 14:00:00 EEST | Press release
Americhem, Inc., a global polymer solutions provider, today announced the launch of nDryve™, a PFAS-free, in-melt surface-modifying technology platform designed to deliver durable multi-fluid repellency against alcohol and other low-surface-energy fluids in fiber systems. As global regulations accelerate the phase-out of per- and polyfluoroalkyl substances (PFAS), manufacturers are under increasing pressure to maintain barrier performance without fluorinated chemistries. nDryve™ was developed to address this shift, offering a PFAS-free, in-melt alternative to conventional surface applied treatments. Engineered for Performance Without PFAS Often referred to as “forever chemicals,” PFAS have come under heightened regulatory scrutiny due to their persistence and potential environmental and health impacts. nDryve™ integrates directly into the polymer during melt processing, embedding surface-modifying functionality within the fiber matrix rather than relying on removable finishes. By engin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom